NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Leman Biotech

Leman Biotech

Private
ShenzhenHealthcare & Life Scienceshttps://lemanbio.com/

Last Round

Series A

Extension

Mar 4, 2026

Total Funding Raised

$60M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Leman Biotech is a biotechnology company that develops next-generation metabolic cancer immunotherapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

cancer immunotherapymetabolic immunotherapyCAR-T therapycell therapymetabolic reprogrammingAI drug discoveryAI biotechclinical-stage biotechT-cell exhaustionarmored CAR-TTIL therapysolid tumor therapyautoimmune disease therapysystemic lupus erythematosusSLE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leman Biotech Comparables

Compare Leman Biotech with similar companies based on industry and business-model similarity.

Leman Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ucello Biotechnology
82%
CARsgen Therapeutics
77%
IASO Bio
76%

Leman Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 4, 2026
Series ANov 13, 2024
AngelJun 18, 2024
AngelJan 18, 2022

Leman Biotech Investors

Notable investors and investment history

Leman Biotech investors
InvestorRounds
中山创业投资有限公司Series A Extension
Fuhui Venture CapitalAngel
Tiantu CapitalAngel
Tailong InvestmentSeries A Extension
5Y CapitalAngel
Zhongshan Venture Capital Co., Ltd.Series A Extension
Yuecai Zhongyin Private Equity Fund ManagementSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    $28M round led by XtalPi and Yuecai Zhongyin.

  • Nov 7, 2025

    Monthly visitors increased 31% MoM.

Leman Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Leman Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leman Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Employee Range4
Year Founded2021
Last FundingMar 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.